Category: Client Objectives

Client Objectives

New Microneedle Can Obliterate Spider Veins in One Sesson

A new microneedle device—the Given Needle—may help eradicate spider veins with one treatment, a new study shows.

Client Objectives

Allergan Wins First Approval for Short-Acting Neurotoxin in Canada

The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.

Client Objectives

China Approves First Recombinant Botulinum Toxin for Glabellar Lines

The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.

Aesthetics

Oncoplastic Breast Surgery Program Receives Center of Excellence Designation

The hospital has been named the world’s first Center of Excellence in oncoplastic breast surgery, recognizing its long-running program that integrates breast cancer removal and reconstruction into a single procedure.

Dermatology

AAD Meeting to Highlight Research on Diet, Skin Aging, and Inflammatory Skin Conditions

Dermatologists will present new research on nutrition’s role in skin aging alongside updates on hair health, acne, and chronic inflammatory diseases.

Rejuvenation

Merz Aesthetics Receives EU Approval for New BELOTERO Balance Indications

Filler cleared for infraorbital hollow and horizontal forehead lines in Europe.